Lista de obras -

A fusion protein between streptavidin and the endogenous TLR4 ligand EDA targets biotinylated antigens to dendritic cells and induces T cell responses in vivo.

scientific article published on 05 September 2013

A peptide inhibitor of FOXP3 impairs regulatory T cell activity and improves vaccine efficacy in mice.

artículo científico publicado en 2010

A recombinant adenovirus encoding hepatitis C virus core and E1 proteins protects mice against cytokine-induced liver damage

artículo científico publicado en 2003

A synthetic peptide from transforming growth factor beta type III receptor inhibits liver fibrogenesis in rats with carbon tetrachloride liver injury

artículo científico publicado en 2003

A synthetic peptide from transforming growth factor-beta1 type III receptor prevents myocardial fibrosis in spontaneously hypertensive rats

artículo científico publicado en 2008

A synthetic peptide from transforming growth factor-β₁ type III receptor inhibits NADPH oxidase and prevents oxidative stress in the kidney of spontaneously hypertensive rats

artículo científico publicado en 2013

Abnormal priming of CD4(+) T cells by dendritic cells expressing hepatitis C virus core and E1 proteins.

artículo científico publicado en 2002

Adjuvant Combination and Antigen Targeting as a Strategy to Induce Polyfunctional and High-Avidity T-Cell Responses against Poorly Immunogenic Tumors

article

B cell epitopes of HIV type 1 p24 capsid protein: a reassessment

artículo científico publicado en 1996

Blockade of TGF-β 1 signalling inhibits cardiac NADPH oxidase overactivity in hypertensive rats.

artículo científico publicado en 2012

CD4+/CD25+ regulatory cells inhibit activation of tumor-primed CD4+ T cells with IFN-gamma-dependent antiangiogenic activity, as well as long-lasting tumor immunity elicited by peptide vaccination.

artículo científico publicado en 2003

CD4-modified synthetic peptides containing phenylalanine inhibit HIV-1 infection in vitro.

artículo científico publicado en 1994

Carcinoembryonic antigen as a target to induce anti-tumor immune responses.

artículo científico publicado en 2004

Cellular immunity to hepatitis C virus core protein and the response to interferon in patients with chronic hepatitis C.

artículo científico publicado en 1998

Characterization of T-cell responses against immunodominant epitopes from hepatitis C virus E2 and NS4a proteins.

artículo científico publicado en 2006

Characterization of an immunologically conserved epitope from hepatitis C virus E2 glycoprotein recognized by HLA-A2 restricted cytotoxic T lymphocytes

artículo científico publicado en 2001

Combined immunization with adjuvant molecules poly(I:C) and anti-CD40 plus a tumor antigen has potent prophylactic and therapeutic antitumor effects

artículo científico publicado en 2007

Detection of anti-hepatitis C virus antibodies by ELISA using synthetic peptides

artículo científico publicado en 1993

Different doses of adenoviral vector expressing IL-12 enhance or depress the immune response to a coadministered antigen: the role of nitric oxide

artículo científico publicado en 1999

Engineered promiscuous T helper peptides for the induction of immune responses

artículo científico publicado en 2006

Engineering Th determinants for efficient priming of humoral and cytotoxic T cell responses

artículo científico publicado en 2003

Enhanced T cell responses against hepatitis C virus by ex vivo targeting of adenoviral particles to dendritic cells

artículo científico publicado en 2011

Enhancement of CD4 and CD8 immunity by anti-CD137 (4-1BB) monoclonal antibodies during hepatitis C vaccination with recombinant adenovirus

artículo científico publicado en 2005

Enhancement of peptide immunogenicity by insertion of a cathepsin B cleavage site between determinants recognized by B and T cells

artículo científico publicado en 1993

Enhancing immunogenicity of a CTL epitope from carcinoembryonic antigen by selective amino acid replacements.

artículo científico publicado en 2002

Fine analysis of immunoreactivity of V3 peptides: antibodies specific for V3 domain of laboratory HIV type 1 strains recognize multiple V3 sequences synthesized from field HIV type 1 isolates

artículo científico publicado en 1996

Further insights on the inhibition of HIV type 1 infection in vitro by CD4-modified synthetic peptides containing phenylalanine

artículo científico publicado en 1996

Helper cell-independent antitumor activity of potent CD8(+) T cell epitope peptide vaccines is dependent upon CD40L.

artículo científico publicado en 2013

Hepatitis C Virus Structural Proteins Impair Dendritic Cell Maturation and Inhibit In Vivo Induction of Cellular Immune Responses

artículo científico publicado en 2003

Identification and characterization of a T-helper peptide from carcinoembryonic antigen.

artículo científico publicado en 2004

Identification of HLA-B27-restricted cytotoxic T lymphocyte epitope from carcinoembryonic antigen

artículo científico publicado en 2002

Identification of an antigenic epitope for helper T lymphocytes from carcinoembryonic antigen

artículo científico publicado en 2002

Identification of peptide inhibitors of transforming growth factor beta 1 using a phage-displayed peptide library

artículo científico publicado en 2007

Immunization against hepatitis C virus with a fusion protein containing the extra domain A from fibronectin and the hepatitis C virus NS3 protein

artículo científico publicado en 2009

Immunization with a tumor-associated CTL epitope plus a tumor-related or unrelated Th1 helper peptide elicits protective CTL immunity

artículo científico publicado en 2001

In vitro and in vivo down-regulation of regulatory T cell activity with a peptide inhibitor of TGF-beta1.

artículo científico publicado en 2008

In vivo cytotoxic T-lymphocyte induction may take place via CD8 T helper lymphocytes

artículo científico publicado en 1995

Induction of Monocyte Chemoattractant Protein-1 and Interleukin-10 by TGF 1 in Melanoma Enhances Tumor Infiltration and Immunosuppression

scientific article published on 15 December 2010

Induction of antibodies against a peptide hapten does not require covalent linkage between the hapten and a class II presentable T helper peptide

scientific article published on 01 June 1991

Induction of cytotoxic T lymphocytes in mice against the principal neutralizing domain of HIV-1 by immunization with an engineered T-cytotoxic-T-helper synthetic peptide construct

scientific article published on 01 April 1992

Induction of cytotoxic T-cell response against hepatitis C virus structural antigens using a defective recombinant adenovirus

artículo científico publicado en 1997

Induction of multiepitopic and long-lasting immune responses against tumour antigens by immunization with peptides, DNA and recombinant adenoviruses expressing minigenes

artículo científico publicado en 2008

Induction of neutralizing antibodies against human immunodeficiency virus type 1 using synthetic peptide constructs containing an immunodominant T-helper cell determinant from vpr.

artículo científico publicado en 1994

Induction of potent and long-lasting CD4 and CD8 T-cell responses against hepatitis C virus by immunization with viral antigens plus poly(I:C) and anti-CD40.

artículo científico publicado en 2007

Insights on the amino acid side-chain interactions of a synthetic T-cell determinant

artículo científico publicado en 1991

Monocyte-derived dendritic cells from HCV-infected patients transduced with an adenovirus expressing NS3 are functional when stimulated with the TLR3 ligand poly(I:C).

artículo científico publicado en 2008

Overcoming class II-linked non-responsiveness to hepatitis B vaccine

artículo científico publicado en 1994

Peptide inhibitors of transforming growth factor-beta enhance the efficacy of antitumor immunotherapy.

artículo científico publicado en 2009

Polarity of immunogens: implications for vaccine design

artículo científico publicado en 1990

Production of interleukin-2 in response to synthetic peptides from hepatitis C virus E1 protein in patients with chronic hepatitis C: relationship with the response to interferon treatment

artículo científico publicado en 1996

Simple strategy to induce antibodies of distinct specificity: Application to the mapping of gp120 and inhibition of HIV-1 infectivity

article

Specific and general HLA-DR binding motifs: comparison of algorithms

artículo científico publicado en 2000

T(h)1 but not T(h)0 cell help is efficient to induce cytotoxic T lymphocytes by immunization with short synthetic peptides

artículo científico publicado en 1999

T-helper cell response to woodchuck hepatitis virus antigens after therapeutic vaccination of chronically-infected animals treated with lamivudine

artículo científico publicado en 2001

The extra domain A from fibronectin targets antigens to TLR4-expressing cells and induces cytotoxic T cell responses in vivo

artículo científico publicado en 2007

Therapeutic vaccination of woodchucks against chronic woodchuck hepatitis virus infection.

artículo científico publicado en 1997

Topical application of a peptide inhibitor of transforming growth factor-beta1 ameliorates bleomycin-induced skin fibrosis

scientific article published on 01 September 2005

Tumor therapy in mice by using a tumor antigen linked to modulin peptides from Staphylococcus epidermidis

artículo científico publicado en 2010

Upregulation of indoleamine 2,3-dioxygenase in hepatitis C virus infection

artículo científico publicado en 2007

Vaccination against hepatitis C virus with dendritic cells transduced with an adenovirus encoding NS3 protein.

artículo científico publicado en 2007

Vaccination with an adenoviral vector encoding hepatitis C virus (HCV) NS3 protein protects against infection with HCV-recombinant vaccinia virus

artículo científico publicado en 2002

Lista de obras de

A fusion protein between streptavidin and the endogenous TLR4 ligand EDA targets biotinylated antigens to dendritic cells and induces T cell responses in vivo.

A peptide inhibitor of FOXP3 impairs regulatory T cell activity and improves vaccine efficacy in mice.

A recombinant adenovirus encoding hepatitis C virus core and E1 proteins protects mice against cytokine-induced liver damage

A synthetic peptide from transforming growth factor beta type III receptor inhibits liver fibrogenesis in rats with carbon tetrachloride liver injury

A synthetic peptide from transforming growth factor-beta1 type III receptor prevents myocardial fibrosis in spontaneously hypertensive rats

A synthetic peptide from transforming growth factor-β₁ type III receptor inhibits NADPH oxidase and prevents oxidative stress in the kidney of spontaneously hypertensive rats

Abnormal priming of CD4(+) T cells by dendritic cells expressing hepatitis C virus core and E1 proteins.

Adjuvant Combination and Antigen Targeting as a Strategy to Induce Polyfunctional and High-Avidity T-Cell Responses against Poorly Immunogenic Tumors

B cell epitopes of HIV type 1 p24 capsid protein: a reassessment

Blockade of TGF-β 1 signalling inhibits cardiac NADPH oxidase overactivity in hypertensive rats.

CD4+/CD25+ regulatory cells inhibit activation of tumor-primed CD4+ T cells with IFN-gamma-dependent antiangiogenic activity, as well as long-lasting tumor immunity elicited by peptide vaccination.

CD4-modified synthetic peptides containing phenylalanine inhibit HIV-1 infection in vitro.

Carcinoembryonic antigen as a target to induce anti-tumor immune responses.

Cellular immunity to hepatitis C virus core protein and the response to interferon in patients with chronic hepatitis C.

Characterization of T-cell responses against immunodominant epitopes from hepatitis C virus E2 and NS4a proteins.

Characterization of an immunologically conserved epitope from hepatitis C virus E2 glycoprotein recognized by HLA-A2 restricted cytotoxic T lymphocytes

Combined immunization with adjuvant molecules poly(I:C) and anti-CD40 plus a tumor antigen has potent prophylactic and therapeutic antitumor effects

Detection of anti-hepatitis C virus antibodies by ELISA using synthetic peptides

Different doses of adenoviral vector expressing IL-12 enhance or depress the immune response to a coadministered antigen: the role of nitric oxide

Engineered promiscuous T helper peptides for the induction of immune responses

Engineering Th determinants for efficient priming of humoral and cytotoxic T cell responses

Enhanced T cell responses against hepatitis C virus by ex vivo targeting of adenoviral particles to dendritic cells

Enhancement of CD4 and CD8 immunity by anti-CD137 (4-1BB) monoclonal antibodies during hepatitis C vaccination with recombinant adenovirus

Enhancement of peptide immunogenicity by insertion of a cathepsin B cleavage site between determinants recognized by B and T cells

Enhancing immunogenicity of a CTL epitope from carcinoembryonic antigen by selective amino acid replacements.

Fine analysis of immunoreactivity of V3 peptides: antibodies specific for V3 domain of laboratory HIV type 1 strains recognize multiple V3 sequences synthesized from field HIV type 1 isolates

Further insights on the inhibition of HIV type 1 infection in vitro by CD4-modified synthetic peptides containing phenylalanine

Helper cell-independent antitumor activity of potent CD8(+) T cell epitope peptide vaccines is dependent upon CD40L.

Hepatitis C Virus Structural Proteins Impair Dendritic Cell Maturation and Inhibit In Vivo Induction of Cellular Immune Responses

Identification and characterization of a T-helper peptide from carcinoembryonic antigen.

Identification of HLA-B27-restricted cytotoxic T lymphocyte epitope from carcinoembryonic antigen

Identification of an antigenic epitope for helper T lymphocytes from carcinoembryonic antigen

Identification of peptide inhibitors of transforming growth factor beta 1 using a phage-displayed peptide library

Immunization against hepatitis C virus with a fusion protein containing the extra domain A from fibronectin and the hepatitis C virus NS3 protein

Immunization with a tumor-associated CTL epitope plus a tumor-related or unrelated Th1 helper peptide elicits protective CTL immunity

In vitro and in vivo down-regulation of regulatory T cell activity with a peptide inhibitor of TGF-beta1.

In vivo cytotoxic T-lymphocyte induction may take place via CD8 T helper lymphocytes

Induction of Monocyte Chemoattractant Protein-1 and Interleukin-10 by TGF 1 in Melanoma Enhances Tumor Infiltration and Immunosuppression

Induction of antibodies against a peptide hapten does not require covalent linkage between the hapten and a class II presentable T helper peptide

Induction of cytotoxic T lymphocytes in mice against the principal neutralizing domain of HIV-1 by immunization with an engineered T-cytotoxic-T-helper synthetic peptide construct

Induction of cytotoxic T-cell response against hepatitis C virus structural antigens using a defective recombinant adenovirus

Induction of multiepitopic and long-lasting immune responses against tumour antigens by immunization with peptides, DNA and recombinant adenoviruses expressing minigenes

Induction of neutralizing antibodies against human immunodeficiency virus type 1 using synthetic peptide constructs containing an immunodominant T-helper cell determinant from vpr.

Induction of potent and long-lasting CD4 and CD8 T-cell responses against hepatitis C virus by immunization with viral antigens plus poly(I:C) and anti-CD40.

Insights on the amino acid side-chain interactions of a synthetic T-cell determinant

Monocyte-derived dendritic cells from HCV-infected patients transduced with an adenovirus expressing NS3 are functional when stimulated with the TLR3 ligand poly(I:C).

Overcoming class II-linked non-responsiveness to hepatitis B vaccine

Peptide inhibitors of transforming growth factor-beta enhance the efficacy of antitumor immunotherapy.

Polarity of immunogens: implications for vaccine design

Production of interleukin-2 in response to synthetic peptides from hepatitis C virus E1 protein in patients with chronic hepatitis C: relationship with the response to interferon treatment

Simple strategy to induce antibodies of distinct specificity: Application to the mapping of gp120 and inhibition of HIV-1 infectivity

Specific and general HLA-DR binding motifs: comparison of algorithms

T(h)1 but not T(h)0 cell help is efficient to induce cytotoxic T lymphocytes by immunization with short synthetic peptides

T-helper cell response to woodchuck hepatitis virus antigens after therapeutic vaccination of chronically-infected animals treated with lamivudine

The extra domain A from fibronectin targets antigens to TLR4-expressing cells and induces cytotoxic T cell responses in vivo

Therapeutic vaccination of woodchucks against chronic woodchuck hepatitis virus infection.

Topical application of a peptide inhibitor of transforming growth factor-beta1 ameliorates bleomycin-induced skin fibrosis

Tumor therapy in mice by using a tumor antigen linked to modulin peptides from Staphylococcus epidermidis

Upregulation of indoleamine 2,3-dioxygenase in hepatitis C virus infection

Vaccination against hepatitis C virus with dendritic cells transduced with an adenovirus encoding NS3 protein.

Vaccination with an adenoviral vector encoding hepatitis C virus (HCV) NS3 protein protects against infection with HCV-recombinant vaccinia virus